G-CSF–treated granulocytes inhibit acute graft-versus-host disease

Vasconcelos, Zilton F. M. ; Santos, Bruna M. dos ; Farache, Julia ; Palmeira, Tereza S. S. ; Areal, R“mulo B. ; Cunha, Jos‚ Marcos T. ; Barcinski, Marcello A. ; Bonomo, Adriana.
Blood ; 107(5): 2192-2199, mar. 2006. ilus, graf
Artículo en Inglés | TXTC | ID: txt-22257

Documentos relacionados

  1. Current Concepts and Advances in Graft-Versus-Host Disease Immunology.
  2. Ambient oxygen levels regulate intestinal dysbiosis and GVHD severity after allogeneic stem cell transplantation.
  3. Lipocalin-2: a novel potential therapy for GVHD.
  4. Graft-versus-host disease is locally maintained in target tissues by resident progenitor-like T cells.
  5. Here, There, and Everywhere: Myeloid-Derived Suppressor Cells in Immunology.
  6. Analysis of the T-cell repertoire and transcriptome identifies mechanisms of regulatory T-cell suppression of GVHD.
  7. USP11 plays a critical role in the onset and progression of acute graft-versus-host disease：Novel target for precision therapeutics.
  8. Endothelial damage and dysfunction in acute graft-versus-host disease.
  9. Granulocyte Transfusions in Patients with Chronic Granulomatous Disease Undergoing Hematopoietic Cell Transplantation or Gene Therapy.
  10. The Absence of IL-12Rß2 Expression on Recipient Nonhematopoietic Cells Diminishes Acute Graft-versus-Host Disease in the Gastrointestinal Tract.